APS
ABBV icon

American Planning Services’s AbbVie ABBV Stock Holding History

American Planning Services’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$236K Buy
+1,195
New +$223K 0.19% 49

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

American Planning Services's ABBV Position: Q3 2024 in Review

American Planning Services opened a new position in AbbVie (ABBV) in Q3 2024: 1,195 shares worth $236K. The stake represents 0.19% of the portfolio and ranks #49 among its holdings.

3,504 funds tracked by Wall St. Rank hold ABBV as of Q3 2024.

  • American Planning Services held 1,195 shares of AbbVie worth $236K as of Q3 2024.
  • AbbVie was a new American Planning Services position in Q3 2024.
  • AbbVie made up 0.19% of American Planning Services's portfolio in Q3 2024, its #49 holding.
  • 3,504 funds tracked by Wall St. Rank held AbbVie as of Q3 2024.

Based on American Planning Services's 13F filing for Q3 2024, filed 14 Nov 2024.